We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

From Sequencing to Interpretation: Bioinformatics Challenges in Next Generation Sequencing Cancer Dx

Video   Oct 06, 2016

 

Next generation sequencing (NGS) technologies are rapidly transforming clinical oncology diagnostics, allowing for dramatically expanded surveillance of nucleic acid signatures to support personalized prognostics and therapeutic interventions. New assay types and clinical targets continue to emerge, as does the associated data volume and complexity, creating unique and exciting challenges for those tasked with managing, analyzing and interpreting the resulting data. These challenges can be of a technical nature, as cancer specimens can be vanishingly small, with degraded nucleic acids, tumor cell heterogeneity and tumor/normal admixture, all of which are likely to produce signal-to-noise problems at the data level. They may also be of a holistic nature. High quality clinical NGS bioinformatics requires teamwork and interconnectedness, not only being responsive to laboratory and clinician needs but also helping to guide and inform laboratory practices, clinical interpretations as well as the overall mission. This lecture will use our experiences at The University of Chicago Medicine to highlight some of the common analytical, technical, and regulatory challenges that bioinformatics groups face when helping to set up oncology genomics clinical diagnostics practices.

 
Company Information
 
 
 

Recommended Videos

SNP Genotyping on qPCR Platforms: Troubleshooting for Amplification and Cluster Separation

Video

Daniel Tsang provides an overview of genotyping using real-time PCR (qPCR) technology, including challenges and ways to overcome these challenges.

WATCH NOW

Ready for a change of scenery?

Video

Get a new perspective on your sample QC with the Agilent 4150 TapeStation system and open up new horizons. Ideal for handling smaller numbers of samples, the system with ScreenTape assays delivers fast, reliable results within any NGS workflow.

WATCH NOW

The Advantages of Machine Learning and Artificial Intelligence in the Drug Discovery Process

Video

Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Diagnostics Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE